Headshot of Eva Yin, General Manager, Oncology Business Unit at AstraZeneca China

My background is in human genomics, population genetics, precision medicine and leading large-scale human genomics studies. I joined AstraZeneca in August 2017 and my role as Vice President and Head of Genome Analytics and Bioinformatics for AstraZeneca’s Centre for Genomics Research (CGR) involves leading the design and implementation of human genomic studies as part of AstraZeneca’s Genomics Initiative. My team applies human genetics to inform and drive novel target discovery, target validation, target safety, precision medicine and late-stage support.

Prior to this, I was a Senior Research Fellow and Group Leader in Computational Genomics within the Department of Medicine at the University of Melbourne, Australia. I was awarded a PhD in Bioinformatics and Biostatistics from the Faculty of Medicine, Dentistry & Health Sciences at the University of Melbourne in 2011.

Over my career, I have made important contributions to human and population genomics, including key contributions to the science of target discovery and variant interpretation. I have also secured prestigious funding from numerous international organisations and regularly publish my work in highly regarded journals.

Through large-scale population genetics and multi-omics, we are discovering novel targets, understanding disease mechanisms, and implementing precision medicine strategies across early R&D.

Slavé Petrovski Vice President, Head of Genome Analytics and Bioinformatics, R&D

Award

Scrip Award, Best Partnership Alliance, 2020

Award

Amgen, AstraZeneca, GSK and Janssen for the UK Biobank Whole Genome Sequencing Project

CURRENT ROLE

Vice President, Head of Genome Analytics and Bioinformatics, R&D

2020

Invited speaker at AWS Re:Invent Conference

2018

Panel speaker at Bloomberg Data for Good Exchange

2018

Completed the initial build of the Genomics Initiative capabilities at AstraZeneca, to drive human genetics-based novel target discovery, target validation, target safety, precision medicine and late-stage support

Featured publications